Talk to Geoffrey
+1 718 618 4302
Search inside this page
Top countries
Publication dates
Publishers
All regions
Free Market Research Guides to Download
» Purchase Premium Reports
1-30 of about 2 600 reports
"Analytical Tool - Antibodies and Peptides in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in the antibody and ...
Declining sales of specific market products has resulted in decelerating growth of the total U.S. denta bone graft substitute and other biomaterials market in 2012. In 2012, the total U.S. market for dental ...
"Analytical Tool- Cancer Immunotherapy" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer. It ...
Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged ...
Finding Opportunities in a Changing Competitive and Patent Landscape This research service evaluates the U.S. qPCR reagents market from 2010 to 2017. The mature qPCR reagents market remains dynamic due ...
STUDY GOALS AND OBJECTIVES BCC Research's goal for this study was to determine the status of proteomic technologies and products and assess their global growth potential over the five-year period from ...
STUDY GOALS AND OBJECTIVES BCC Research's goal for this study is to provide a comprehensive analysis of the bioinformatic market by reviewing the recent advances in high-throughput ?omic technologies and ...
STUDY GOALS AND OBJECTIVES This report is an update of an earlier (2008) BCC report on the worldwide electrophoresis industry. This report will 'determine the current status of the electrophoresis industry ...
STUDY GOALS AND OBJECTIVES In 2007, the Nobel Prize Committee stated that, ?Giant magnetoresistance (GMR) can be considered one of the first real applications of the promising field of nanotechnology.? ...
REPORT SCOPE INTRODUCTION Biomarkers are measurable and quantifiable biological indicators that can be used to diagnose or predict disease, monitor disease progression, indicate what treatment options ...
"Analytical Tool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment of cancer. ...
Proteins exhibit high specificity and less immunogenicity and are widely used as therapeutic agents in the treatment of various disorders and diseases. There are more than 200 protein-based products currently ...
A biomaterial is a natural or synthetic material suited to replace or treat natural body tissues and organs on interaction with biological systems. It traces its history to more than 2000 years ago, when ...
The computational biology market is predicted to have a notable growth owing to its wide use by biotechnology and pharmaceutical companies to reduce the incidences of late stage failures of their drugs ...
The biotechnology market is expected to show substantial growth over the forecast period owing to regulatory support offered to various companies operating in the biotechnology field. In addition, the ...
This triple analysis focuses on cancer drug development strategies by the mechanism/target/effect of Cancer Vaccines and by the two compound strategies of Antibodies and Peptides. Each of these three individual ...
This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors and by the compound strategy of Antibodies. ...
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Leukemia), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Antibodies). ...
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Antibodies). ...
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Antibodies). ...
Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged ...
Product Description The report ?Antibody Technologies and Attrition Rates - an industry analysis 2013? is based on the identification of the antibody generation technologies of 504 naked antibodies in ...
Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the ...
The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare ...
The Pharmacogenomic Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomic partnering deals and agreements entered into by the worlds ...
The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare ...
INTRODUCTION Recent advances allowing for the better understanding of the ways in which living DNA creates the materials of life have opened remarkable new possibilities in materials science and chemical ...
Editor Notes In March 2013, a series of policies related to the biomaterials industry were published in China. The Chinese government paid more attention to green agriculture and environmental protection. ...
Editor Notes Feb. 2013 is the first month of the traditional Chinese year, and many enterprises have already published their performance pre-announcement for the year 2012. Some witnessed a better-than-expected ...
This report explores the recent surge in clinical genome sequencing, from the point of view of the sequencing providers, the medical organizations delivering these services, and the start-ups offering ...
» Download Public Reports
About 6 200 reports
... And production of rare, fully human monoclonal antibodies are offered by vivalis. Through these programs, vivalis receives payments associated with the funding of discovery research, an upfront payment, clinical ...
» Read our Company Profiles
99 CompaniesReportlinker.com © Copyright 2013. All rights reserved.